Geode Capital Management LLC Has $14.70 Million Holdings in Orthofix Medical Inc. (NASDAQ:OFIX)

Geode Capital Management LLC lifted its stake in Orthofix Medical Inc. (NASDAQ:OFIX) by 0.3% during the 4th quarter, HoldingsChannel reports. The fund owned 841,637 shares of the medical device company’s stock after buying an additional 2,448 shares during the period. Geode Capital Management LLC’s holdings in Orthofix Medical were worth $14,699,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of OFIX. Vanguard Group Inc. grew its position in Orthofix Medical by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 2,126,785 shares of the medical device company’s stock worth $37,134,000 after purchasing an additional 12,286 shares during the last quarter. Emerald Advisers LLC lifted its stake in shares of Orthofix Medical by 12.2% in the fourth quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company’s stock valued at $14,359,000 after buying an additional 89,717 shares during the period. Charles Schwab Investment Management Inc. grew its position in Orthofix Medical by 4.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 339,531 shares of the medical device company’s stock worth $5,928,000 after buying an additional 14,724 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Orthofix Medical by 244.1% during the fourth quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company’s stock valued at $5,070,000 after acquiring an additional 205,972 shares during the period. Finally, Teacher Retirement System of Texas raised its holdings in Orthofix Medical by 90.0% in the 4th quarter. Teacher Retirement System of Texas now owns 135,009 shares of the medical device company’s stock valued at $2,357,000 after acquiring an additional 63,939 shares in the last quarter. Institutional investors own 89.76% of the company’s stock.

Insiders Place Their Bets

In other Orthofix Medical news, insider Lucas Vitale sold 4,287 shares of the business’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total value of $71,164.20. Following the transaction, the insider now directly owns 135,317 shares in the company, valued at $2,246,262.20. The trade was a 3.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jorge Andres Cedron sold 3,816 shares of the firm’s stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $13.31, for a total transaction of $50,790.96. Following the sale, the insider now directly owns 42,500 shares of the company’s stock, valued at approximately $565,675. The trade was a 8.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 9,242 shares of company stock worth $141,710 over the last three months. 2.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on OFIX shares. StockNews.com raised Orthofix Medical from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. Canaccord Genuity Group reissued a “buy” rating and issued a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $23.33.

Orthofix Medical Price Performance

Orthofix Medical stock opened at $13.03 on Monday. The business has a 50 day simple moving average of $16.25 and a 200 day simple moving average of $17.17. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The company has a market capitalization of $508.46 million, a PE ratio of -4.16 and a beta of 0.99. Orthofix Medical Inc. has a one year low of $12.08 and a one year high of $20.73.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.